+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028

  • ID: 5527517
  • Report
  • January 2022
  • Region: India
  • 65 Pages
  • DPI Research
UP TO OFF until Aug 31st 2022

Indian Non-Invasive Prenatal Testing (NIPT) Market size is expected to reach USD 62 million by 2028. The market is expected to expand at a CAGR of more than 11% from 2022 to 2028.





India Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetuses, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing. The market shows high potential for growth in the future.

This new market report presents a comprehensive study of the entire Indian non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018-2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in India.

This Comprehensive India’s Non-Invasive Prenatal Testing Market Research Report Provides:

  • To Analyse the Historical Growth in the Market Size of the India Non–Invasive Prenatal Testing Market from 2018 to 2021
  • To Estimate and Forecast the Market Size of the India Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
  • Evaluates the Number of NIPT Tests Performed in India with Six Years Forecast
  • Assessment of Market Potential and Opportunities for this Innovation-Driven India Non–Invasive Prenatal Testing Market with Six Years Forecast
  • Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
  • Detailed Insights into the Regulatory Framework of the India Non–Invasive Prenatal Testing Market 
  • Features Reimbursement Patterns of the India Non–Invasive Prenatal Testing Market 
  • Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
  • A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development

The Leading Companies for the Indian Non-Invasive Prenatal Testing Market are Listed Below:

  • Medgenome
  • DNA Labs India
  • LifeCell
  • Apollo Centre for Fetal Medicine
  • Igenomix India
  • Fortis Healthcare Limited
  • DNA Forensics Laboratory Pvt. Ltd.
  • Thyrocare Technologies Limited

Key Questions Answered in this Report:

  • What is the current scenario of the Indian non-invasive prenatal testing market?
  • What is the total market size and forecast (until 2028) for the Indian non-invasive prenatal testing market?
  • How has the potential Indian market performed so far and how will it perform in the coming years?
  • How many NIPT tests were performed in India during 2018-2028?
  • What are the key marketed NIPT tests available in India?
  • What are the major drivers of the Indian non-invasive prenatal testing market?
  • What are the major inhibitors of the Indian non-invasive prenatal testing market?
  • What is the reimbursement pattern in the Indian non-invasive prenatal testing market?
  • What is the regulatory framework in the Indian non-invasive prenatal testing market?
  • What are the major deals and agreement happenings in the non-invasive prenatal testing market?
  • Who are the top Indian market players? What are their happenings, current developments, and scenarios?
  • How is the Indian market predicted to develop in the future?
Frequently Asked Questions about the Indian Non-Invasive Prenatal Testing (NIPT) Market

What is the estimated value of the Indian Non-Invasive Prenatal Testing (NIPT) Market?

The Indian Non-Invasive Prenatal Testing (NIPT) Market was estimated to be valued at $28.0 Million in 2021.

What is the growth rate of the Indian Non-Invasive Prenatal Testing (NIPT) Market?

The growth rate of the Indian Non-Invasive Prenatal Testing (NIPT) Market is 12.0%, with an estimated value of $62.0 Million by 2028.

What is the forecasted size of the Indian Non-Invasive Prenatal Testing (NIPT) Market?

The Indian Non-Invasive Prenatal Testing (NIPT) Market is estimated to be worth $62.0 Million by 2028.

Who are the key companies in the Indian Non-Invasive Prenatal Testing (NIPT) Market?

Key companies in the Indian Non-Invasive Prenatal Testing (NIPT) Market include Medgenome, DNA Labs India, LifeCell, Apollo Centre for Fetal Medicine, Igenomix India, Fortis Healthcare Limited and Thyrocare Technologies Limited.

Table of Contents


1. Executive Summary2. India Actual Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018-2028)3. India Potential Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018-2028)4. India Actual Non-Invasive Prenatal Testing Market Size and Forecast (2018-2028)5. India Potential Non-Invasive Prenatal Testing Market Size and Forecast (2018-2028)6. India Non-Invasive Prenatal Testing Market Growth Drivers and Challenges7. Non-Invasive Prenatal Testing Comparative Analysis8. Reimbursement Environment of the India Non-Invasive Prenatal Testing Market9. Regulation Framework of the India Non-Invasive Prenatal Testing Market
10. Major Deals and Agreements in the Non-Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals

11. Key Companies Analysis
11.1 Medgenome
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Recent Development
11.2 DNA Labs India
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Recent Development
11.3 LifeCell
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Recent Development
11.4 Apollo Centre for Fetal Medicine
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Recent Development
11.5 Igenomix India
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Recent Development
11.6 Fortis Healthcare Limited
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Recent Development
11.7 DNA Forensics Laboratory Pvt. Ltd
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Recent Development
11.8 Thyrocare Technologies Limited
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Recent Development

List of Tables:
Table 7-1: Non-Invasive Prenatal Testing - Comparative Tests Analysis
Table 10-1: Collaboration Deals in the Non-Invasive Prenatal Testing Market
Table 10-2: Venture Capital Investment in the Non-Invasive Prenatal Testing Market
Table 10-3: Merger & Acquisition in the Non-Invasive Prenatal Testing Market
Table 10-4: Exclusive Agreement in the Non-Invasive Prenatal Testing Market
Table 10-5: Licensing Agreement in the Non-Invasive Prenatal Testing Market
Table 10-6: Distribution Agreement in the Non-Invasive Prenatal Testing Market
Table 10-7: Partnership Deals in the Non-Invasive Prenatal Testing Market

List of Figures:
Figure 2-1: India Actual NIPT Test Volume (Number),2018-2021
Figure 2-2: India Actual NIPT Test Volume Forecast (Number),2022-2028
Figure 3-1: India Potential NIPT Test Volume (Number),2018-2021
Figure 3-2: India Potential NIPT Test Volume Forecast (Number),2022-2028
Figure 4-1: India Actual NIPT Test Market Size (Million US$),2018-2021
Figure 4-2: India Actual NIPT Test Market Size Forecast (Million US$),2022-2028
Figure 5-1: India Potential NIPT Test Market Size (Million US$),2018-2021
Figure 5-2: India Potential NIPT Test Market Size Forecast (Million US$),2022-2028

Samples

Loading
LOADING...

Companies Mentioned

  • Medgenome
  • DNA Labs India
  • LifeCell
  • Apollo Centre for Fetal Medicine
  • Igenomix India
  • Fortis Healthcare Limited
  • DNA Forensics Laboratory Pvt. Ltd.
  • Thyrocare Technologies Limited